Detalhe da pesquisa
1.
Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32229492
2.
A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method.
J Antimicrob Chemother
; 75(7): 1799-1806, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32330938
3.
Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
J Antimicrob Chemother
; 75(1): 140-148, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665417
4.
Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.
J Antimicrob Chemother
; 74(8): 2247-2254, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106352
5.
Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model.
J Antimicrob Chemother
; 73(3): 709-719, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29253153